Fluorescent non-canonical amino acid provides insight into the human serotonin transporter.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
27 Oct 2024
Historique:
received: 12 01 2024
accepted: 17 10 2024
medline: 28 10 2024
pubmed: 28 10 2024
entrez: 28 10 2024
Statut: epublish

Résumé

The serotonin transporter (SERT), responsible for the reuptake of released serotonin, serves as a major target for antidepressants and psychostimulants. Nevertheless, refining the mechanistic models for SERT remains challenging. Here, we expand the molecular understanding of the binding of ions, substrates, and inhibitors to SERT by incorporating the fluorescent non-canonical amino acid Anap through genetic code expansion. We elucidate steady-state changes in conformational dynamics of purified SERT with Anap inserted at intracellular- or extracellular sites. This uncovers the competitive mechanisms underlying cation binding and assigns distinct binding- and allosteric coupling patterns for several inhibitors and substrates. Finally, we track in real-time conformational transitions in response to the interaction with Na

Identifiants

pubmed: 39463388
doi: 10.1038/s41467-024-53584-9
pii: 10.1038/s41467-024-53584-9
doi:

Substances chimiques

Serotonin Plasma Membrane Transport Proteins 0
Serotonin 333DO1RDJY
Amino Acids 0
SLC6A4 protein, human 0
Sodium 9NEZ333N27
Fluorescent Dyes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9267

Subventions

Organisme : Novo Nordisk Fonden (Novo Nordisk Foundation)
ID : NNF22OC0079091
Organisme : Sundhed og Sygdom, Det Frie Forskningsråd (Medical Sciences, Danish Council for Independent Research)
ID : 1030-00036B
Organisme : Carlsbergfondet (Carlsberg Foundation)
ID : CF20-0345

Informations de copyright

© 2024. The Author(s).

Références

Cheng, M. H. & Bahar, I. Monoamine transporters: structure, intrinsic dynamics and allosteric regulation. Nat. Struct. Mol. Biol. 26, 545–556 (2019).
pubmed: 31270469 pmcid: 6712983 doi: 10.1038/s41594-019-0253-7
Bowman, M. A. & Daws, L. C. Targeting serotonin transporters in the treatment of juvenile and adolescent depression. Front Neurosci. 13, 156 (2019).
pubmed: 30872996 pmcid: 6401641 doi: 10.3389/fnins.2019.00156
Kristensen, A. S. et al. SLC6 neurotransmitter transporters: structure, function, and regulation. Pharm. Rev. 63, 585–640 (2011).
pubmed: 21752877 doi: 10.1124/pr.108.000869
Rudnick, G. & Sandtner, W. Serotonin transport in the 21st century. J. Gen. Physiol. 151, 1248–1264 (2019).
pubmed: 31570504 pmcid: 6829555 doi: 10.1085/jgp.201812066
Nielsen, J. C. et al. Structure of the human dopamine transporter in complex with cocaine. Nature 632, 678–685 (2024).
pubmed: 39112703 doi: 10.1038/s41586-024-07804-3
Coleman, J. A., Green, E. M. & Gouaux, E. X-ray structures and mechanism of the human serotonin transporter. Nature 532, 334–339 (2016).
pubmed: 27049939 pmcid: 4898786 doi: 10.1038/nature17629
Hu, T. et al. Transport and inhibition mechanisms of the human noradrenaline transporter. Nature 632, 930–937 (2024).
Yamashita, A., Singh, S. K., Kawate, T., Jin, Y. & Gouaux, E. Crystal structure of a bacterial homologue of Na + /Cl–dependent neurotransmitter transporters. Nature 437, 215–223 (2005).
pubmed: 16041361 doi: 10.1038/nature03978
Yang, D. & Gouaux, E. Illumination of serotonin transporter mechanism and role of the allosteric site. Sci. Adv. 7, eabl3857 (2021).
pubmed: 34851672 pmcid: 8635421 doi: 10.1126/sciadv.abl3857
Coleman, J. A. et al. Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport. Nature 569, 141–145 (2019).
pubmed: 31019304 pmcid: 6750207 doi: 10.1038/s41586-019-1135-1
Merkle, P. S. et al. Substrate-modulated unwinding of transmembrane helices in the NSS transporter LeuT. Sci. Adv. 4, eaar6179 (2018).
pubmed: 29756037 pmcid: 5947982 doi: 10.1126/sciadv.aar6179
Nelson, P. J. & Rudnick, G. Coupling between platelet 5-hydroxytryptamine and potassium transport. J. Biol. Chem. 254, 10084–10089 (1979).
pubmed: 489585 doi: 10.1016/S0021-9258(19)86675-9
Ni, Y. G. et al. A lithium-induced conformational change in serotonin transporter alters cocaine binding, ion conductance, and reactivity of Cys-109. J. Biol. Chem. 276, 30942–30947 (2001).
pubmed: 11408487 doi: 10.1074/jbc.M104653200
Rudnick, G. & Nelson, P. J. Platelet 5-hydroxytryptamine transport, an electroneutral mechanism coupled to potassium. Biochemistry 17, 4739–4742 (1978).
pubmed: 728383 doi: 10.1021/bi00615a021
Schicker, K. et al. Unifying concept of serotonin transporter-associated currents. J. Biol. Chem. 287, 438–445 (2012).
pubmed: 22072712 doi: 10.1074/jbc.M111.304261
Billesbolle, C. B. et al. Transition metal ion FRET uncovers K(+) regulation of a neurotransmitter/sodium symporter. Nat. Commun. 7, 12755 (2016).
pubmed: 27678200 pmcid: 5052704 doi: 10.1038/ncomms12755
Schmidt, S. G. et al. The dopamine transporter antiports potassium to increase the uptake of dopamine. Nat. Commun. 13, 2446 (2022).
pubmed: 35508541 pmcid: 9068915 doi: 10.1038/s41467-022-30154-5
Schmidt, S. G., Nygaard, A., Mindell, J. A. & Loland, C. J. Exploring the K+ binding site and its coupling to transport in the neurotransmitter: sodium symporter LeuT. (eLife Sciences Publications, Ltd, 2023).
Bhat, S. et al. Handling of intracellular K(+) determines voltage dependence of plasmalemmal monoamine transporter function. Elife 10, e67996 (2021).
pubmed: 34061030 pmcid: 8192120 doi: 10.7554/eLife.67996
Williams, R. S. & Harwood, A. J. Lithium therapy and signal transduction. Trends Pharm. Sci. 21, 61–64 (2000).
pubmed: 10664610 doi: 10.1016/S0165-6147(99)01428-5
Mager, S. et al. Conducting states of a mammalian serotonin transporter. Neuron 12, 845–859 (1994).
pubmed: 8161456 doi: 10.1016/0896-6273(94)90337-9
Lin, F., Lester, H. A. & Mager, S. Single-channel currents produced by the serotonin transporter and analysis of a mutation affecting ion permeation. Biophysical J. 71, 3126–3135 (1996).
doi: 10.1016/S0006-3495(96)79506-1
Moller, I. R. et al. Conformational dynamics of the human serotonin transporter during substrate and drug binding. Nat. Commun. 10, 1687 (2019).
pubmed: 30976000 pmcid: 6459873 doi: 10.1038/s41467-019-09675-z
Gunnoo, S. B. & Madder, A. Chemical protein modification through cysteine. Chembiochem 17, 529–553 (2016).
pubmed: 26789551 doi: 10.1002/cbic.201500667
Chen, J.-G., Liu-Chen, S. & Rudnick, G. External cysteine residues in the serotonin transporter. Biochemistry 36, 1479–1486 (1997).
pubmed: 9063896 doi: 10.1021/bi962256g
Chin, J. W. Expanding and reprogramming the genetic code. Nature 550, 53–60 (2017).
pubmed: 28980641 doi: 10.1038/nature24031
Lee, H. S., Guo, J., Lemke, E. A., Dimla, R. D. & Schultz, P. G. Genetic incorporation of a small, environmentally sensitive, fluorescent probe into proteins in Saccharomyces cerevisiae. J. Am. Chem. Soc. 131, 12921–12923 (2009).
pubmed: 19702307 pmcid: 2873857 doi: 10.1021/ja904896s
Chatterjee, A., Guo, J., Lee, H. S. & Schultz, P. G. A genetically encoded fluorescent probe in mammalian cells. J. Am. Chem. Soc. 135, 12540–12543 (2013).
pubmed: 23924161 pmcid: 3783214 doi: 10.1021/ja4059553
Noren, C. J., Anthony-Cahill, S. J., Griffith, M. C. & Schultz, P. G. A general method for site-specific incorporation of unnatural amino acids into proteins. Science 244, 182–188 (1989).
pubmed: 2649980 doi: 10.1126/science.2649980
Puljung, M. C. ANAP: A versatile, fluorescent probe of ion channel gating and regulation. Methods Enzymol. 654, 49–84 (2021).
pubmed: 34120725 doi: 10.1016/bs.mie.2021.01.048
Huang, Y. Z. et al. TRPV1 analgesics disturb core body temperature via a biased allosteric mechanism involving conformations distinct from that for nociception. Neuron 112, 1815–1831 e4 (2024).
pubmed: 38492574 doi: 10.1016/j.neuron.2024.02.016
Soh, M. S., Estrada-Mondragon, A., Durisic, N., Keramidas, A. & Lynch, J. W. Probing the structural mechanism of partial agonism in glycine receptors using the fluorescent artificial amino acid, ANAP. ACS Chem. Biol. 12, 805–813 (2017).
pubmed: 28121133 doi: 10.1021/acschembio.6b00926
Dabrowski, M., Bukowy-Bieryllo, Z. & Zietkiewicz, E. Translational readthrough potential of natural termination codons in eucaryotes–The impact of RNA sequence. RNA Biol. 12, 950–958 (2015).
pubmed: 26176195 pmcid: 4615788 doi: 10.1080/15476286.2015.1068497
Bartoschek, M. D. et al. Identification of permissive amber suppression sites for efficient non-canonical amino acid incorporation in mammalian cells. Nucleic Acids Res 49, e62 (2021).
pubmed: 33684219 pmcid: 8216290 doi: 10.1093/nar/gkab132
Kalstrup, T. & Blunck, R. Reinitiation at non-canonical start codons leads to leak expression when incorporating unnatural amino acids. Sci. Rep. 5, 11866 (2015).
pubmed: 26153354 pmcid: 4648390 doi: 10.1038/srep11866
Kalstrup, T. & Blunck, R. Dynamics of internal pore opening in K(V) channels probed by a fluorescent unnatural amino acid. Proc. Natl Acad. Sci. USA 110, 8272–8277 (2013).
pubmed: 23630265 pmcid: 3657800 doi: 10.1073/pnas.1220398110
Aman, T. K., Gordon, S. E. & Zagotta, W. N. Regulation of CNGA1 Channel Gating by Interactions with the Membrane. J. Biol. Chem. 291, 9939–9947 (2016).
pubmed: 26969165 pmcid: 4858998 doi: 10.1074/jbc.M116.723932
Zagotta, W. N., Gordon, M. T., Senning, E. N., Munari, M. A. & Gordon, S. E. Measuring distances between TRPV1 and the plasma membrane using a noncanonical amino acid and transition metal ion FRET. J. Gen. Physiol. 147, 201–216 (2016).
pubmed: 26755770 pmcid: 4727949 doi: 10.1085/jgp.201511531
Liu, W., Brock, A., Chen, S., Chen, S. & Schultz, P. G. Genetic incorporation of unnatural amino acids into proteins in mammalian cells. Nat. Methods 4, 239–244 (2007).
pubmed: 17322890 doi: 10.1038/nmeth1016
Schmied, W. H., Elsasser, S. J., Uttamapinant, C. & Chin, J. W. Efficient multisite unnatural amino acid incorporation in mammalian cells via optimized pyrrolysyl tRNA synthetase/tRNA expression and engineered eRF1. J. Am. Chem. Soc. 136, 15577–15583 (2014).
pubmed: 25350841 pmcid: 4333590 doi: 10.1021/ja5069728
Harder, D. & Fotiadis, D. Measuring substrate binding and affinity of purified membrane transport proteins using the scintillation proximity assay. Nat. Protoc. 7, 1569–1578 (2012).
pubmed: 22864198 doi: 10.1038/nprot.2012.090
El-Kasaby, A. et al. Mutations in the carboxyl-terminal SEC24 binding motif of the serotonin transporter impair folding of the transporter. J. Biol. Chem. 285, 39201–39210 (2010).
pubmed: 20889976 pmcid: 2998113 doi: 10.1074/jbc.M110.118000
Tavoulari, S. et al. Two Na+ sites control conformational change in a neurotransmitter transporter homolog. J. Biol. Chem. 291, 1456–1471 (2016).
pubmed: 26582198 doi: 10.1074/jbc.M115.692012
Langer, A. et al. A new spectral shift-based method to characterize molecular interactions. Assay. Drug Dev. Technol. 20, 83–94 (2022).
pubmed: 35171002 pmcid: 8968852 doi: 10.1089/adt.2021.133
Larsen, M. B. et al. Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation. J. Neurosci. 31, 6605–6615 (2011).
pubmed: 21525301 pmcid: 3107525 doi: 10.1523/JNEUROSCI.0576-11.2011
Felts, B. et al. The two Na+ sites in the human serotonin transporter play distinct roles in the ion coupling and electrogenicity of transport. J. Biol. Chem. 289, 1825–1840 (2014).
pubmed: 24293367 doi: 10.1074/jbc.M113.504654
Shi, L., Quick, M., Zhao, Y., Weinstein, H. & Javitch, J. A. The mechanism of a neurotransmitter:sodium symporter–inward release of Na+ and substrate is triggered by substrate in a second binding site. Mol. Cell 30, 667–677 (2008).
pubmed: 18570870 pmcid: 2826427 doi: 10.1016/j.molcel.2008.05.008
Borre, L., Andreassen, T. F., Shi, L., Weinstein, H. & Gether, U. The second sodium site in the dopamine transporter controls cation permeation and is regulated by chloride. J. Biol. Chem. 289, 25764–25773 (2014).
pubmed: 25063810 pmcid: 4162178 doi: 10.1074/jbc.M114.574269
Yang, D., Zhao, Z., Tajkhorshid, E. & Gouaux, E. Structures and membrane interactions of native serotonin transporter in complexes with psychostimulants. Proc. Natl Acad. Sci. 120, e2304602120 (2023).
pubmed: 37436958 pmcid: 10629533 doi: 10.1073/pnas.2304602120
Jacobs, M. T., Zhang, Y. W., Campbell, S. D. & Rudnick, G. Ibogaine, a noncompetitive inhibitor of serotonin transport, acts by stabilizing the cytoplasm-facing state of the transporter. J. Biol. Chem. 282, 29441–29447 (2007).
pubmed: 17698848 doi: 10.1074/jbc.M704456200
Rudnick, G. & Wall, S. C. The molecular mechanism of “ecstasy” [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc. Natl. Acad. Sci. USA 89, 1817–1821 (1992).
Henry, L. K. et al. Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants*. J. Biol. Chem. 281, 2012–2023 (2006).
pubmed: 16272152 doi: 10.1074/jbc.M505055200
Krout, D. et al. Inhibition of the serotonin transporter is altered by metabolites of selective serotonin and norepinephrine reuptake inhibitors and represents a caution to acute or chronic treatment paradigms. ACS Chem. Neurosci. 8, 1011–1018 (2017).
pubmed: 27959497 doi: 10.1021/acschemneuro.6b00343
Kilic, F., Murphy, D. L. & Rudnick, G. A human serotonin transporter mutation causes constitutive activation of transport activity. Mol. Pharmacol. 64, 440–446 (2003).
pubmed: 12869649 doi: 10.1124/mol.64.2.440
Burtscher, V., Schicker, K., Freissmuth, M. & Sandtner, W. Kinetic models of secondary active transporters. Int. J. Mol. Sci. 20, 5365 (2019).
Szollosi, D. & Stockner, T. Investigating the mechanism of sodium binding to SERT using direct simulations. Front Cell Neurosci. 15, 673782 (2021).
pubmed: 34040506 pmcid: 8141550 doi: 10.3389/fncel.2021.673782
Tan, J. et al. Molecular basis of human noradrenaline transporter reuptake and inhibition. Nature 632, 921–929 (2024).
Zhou, Y., Zomot, E. & Kanner, B. I. Identification of a lithium interaction site in the gamma-aminobutyric acid (GABA) transporter GAT-1. J. Biol. Chem. 281, 22092–22099 (2006).
pubmed: 16757479 doi: 10.1074/jbc.M602319200
Pospisil, P. et al. Fluorescence quenching of (dimethylamino)naphthalene dyes Badan and Prodan by tryptophan in cytochromes P450 and micelles. J. Phys. Chem. B 118, 10085–10091 (2014).
pubmed: 25079965 pmcid: 4148165 doi: 10.1021/jp504625d
Dai, G., Aman, T. K., DiMaio, F. & Zagotta, W. N. The HCN channel voltage sensor undergoes a large downward motion during hyperpolarization. Nat. Struct. Mol. Biol. 26, 686–694 (2019).
pubmed: 31285608 pmcid: 6692172 doi: 10.1038/s41594-019-0259-1
Mitchell, A. L., Addy, P. S., Chin, M. A. & Chatterjee, A. A unique genetically encoded FRET pair in mammalian cells. Chembiochem 18, 511–514 (2017).
pubmed: 28093840 doi: 10.1002/cbic.201600668
Madeira, F. et al. Search and sequence analysis tools services from EMBL-EBI in 2022. Nucleic acids Res. 50, W276–W279 (2022).
pubmed: 35412617 pmcid: 9252731 doi: 10.1093/nar/gkac240
Robert, X. & Gouet, P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 42, W320–W324 (2014).
pubmed: 24753421 pmcid: 4086106 doi: 10.1093/nar/gku316

Auteurs

Andreas Nygaard (A)

Department of Neuroscience, University of Copenhagen, Copenhagen, Denmark.

Linda G Zachariassen (LG)

Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.

Kathrine S Larsen (KS)

Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.

Anders S Kristensen (AS)

Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.

Claus J Loland (CJ)

Department of Neuroscience, University of Copenhagen, Copenhagen, Denmark. cllo@sund.ku.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH